<code id='44FBDE588B'></code><style id='44FBDE588B'></style>
    • <acronym id='44FBDE588B'></acronym>
      <center id='44FBDE588B'><center id='44FBDE588B'><tfoot id='44FBDE588B'></tfoot></center><abbr id='44FBDE588B'><dir id='44FBDE588B'><tfoot id='44FBDE588B'></tfoot><noframes id='44FBDE588B'>

    • <optgroup id='44FBDE588B'><strike id='44FBDE588B'><sup id='44FBDE588B'></sup></strike><code id='44FBDE588B'></code></optgroup>
        1. <b id='44FBDE588B'><label id='44FBDE588B'><select id='44FBDE588B'><dt id='44FBDE588B'><span id='44FBDE588B'></span></dt></select></label></b><u id='44FBDE588B'></u>
          <i id='44FBDE588B'><strike id='44FBDE588B'><tt id='44FBDE588B'><pre id='44FBDE588B'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:871
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Sudafed saga points to U.S. issues with evaluating older drugs
          Sudafed saga points to U.S. issues with evaluating older drugs

          PATRICKT.FALLON/AFPviaGettyImagesYouwouldhavebeenforgivenforbeingsurprisedonSept.12whenapanelofadvis

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

          WRAIRWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo